SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Laumann EO, Nicolosi A, Glasser DB et al. Sexual problems among women and men aged 40–80 y: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. Int J Impot Res 2005; 17: 3957
  • 2
    NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA 1993; 270: 8390
  • 3
    Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Construction of a surrogate variable for impotence in the Massachusetts Male Aging Study. J Clin Epidemiol 1994; 47: 45767
  • 4
    Althof SE. Quality of life and erectile dysfunction. Urology 2002; 59: 80310
  • 5
    Boolell M, Allen MJ, Ballard SA et al. Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res 1996; 8: 4752
  • 6
    Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med 1998; 338: 1397404
  • 7
    Dinsmore WW, Hodges M, Hargreaves C, Osterloh IH, Smith MD, Rosen RC. Sildenafil citrate (Viagra) in erectile dysfunction: near normalization in men with broad-spectrum erectile dysfunction compared with age-matched healthy control subjects. Urology 1999; 53: 8005
  • 8
    Eardley I, Morgan R, Dinsmore W, Yates P, Boolell M. Efficacy and safety of sildenafil citrate in the treatment of men with mild to moderate erectile dysfunction. Br J Psychiatry 2001; 178: 32530
  • 9
    Jiann BP, Yu CC, Tsai JY, Wu TT, Lee YH, Huang JK. What to learn about sildenafil in the treatment of erectile dysfunction from 3-year clinical experience. Int J Impot Res 2003; 15: 4127
  • 10
    McCullough AR, Barada JH, Fawzy A, Guay AT, Hatzichristou D. Achieving treatment optimization with sildenafil citrate (Viagra®) in patients with erectile dysfunction. Urology 2002; 60: 2838
  • 11
    Hatzichristou D, Moysidis K, Apostolidis A et al. Sildenafil failures may be due to inadequate patient instructions and follow-up: a study on 100 non-responders. Eur Urol 2005; 47: 51822
  • 12
    Hatzimouratidis K, Hatzichristou DG. A comparative review of the options for treatment of erectile dysfunction: which treatment for which patient? Drugs 2005; 65: 162150
  • 13
    Hatzimouratidis K, Hatzichristou D. Phosphodiesterase type 5 inhibitors: the day after. Eur Urol 2007; 51: 7588
  • 14
    Mulhall JP, Levine LA, Jünemann KP. Erection hardness, a unifying factor for defining response in the treatment of erectile dysfunction. Urology 2006; 68: 1725
  • 15
    Mulhall J, Althof S, Brock G, Goldstein I, Jünemann K-P, Kirby M. Erectile dysfunction: monitoring response to treatment in clinical practice – recommendations of an international consensus panel. J Sex Med 2007; 4: 44864
  • 16
    Glina S, Bertero E, Claro J et al. Efficacy and safety of flexible-dose oral sildenafil citrate (Viagra) in the treatment of erectile dysfunction in Brazilian and Mexican men. Int J Impot Res 2002; 14 (Suppl. 2): S2732
  • 17
    McCullough AR, Carson C, Hatzichristou D. A prospective study of the beneficial effects of dose optimization and customized instructions on patient satisfaction with sildenafil citrate (VIAGRA®) for erectile dysfunction. Urology 2006; 68: 3846
  • 18
    Steidle C, McCullough A, Kaminetsky J et al. Early sildenafil dose optimization and personalized instruction improves the frequency, flexibility, and success of sexual intercourse in men with erectile dysfunction. Int J Impot Res 2007; 19: 15460
  • 19
    Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 82230
  • 20
    Porst H, Gilbert C, Collins S et al. Development and validation of the Quality of Erection Questionnaire. J Sex Med 2007; 4: 37281
  • 21
    Mulhall JP, King R, Kirby M et al. Evaluating the sexual experience in men. Validation of the Sexual Experience Questionnaire. J Sex Med 2008; 5: 36576
  • 22
    Althof SE, Corty EW, Levine SB et al. EDITS: development of questionnaires for evaluating satisfaction with treatments for erectile dysfunction. Urology 1999; 53: 7939
  • 23
    Litwin MS, Nied RJ, Dhanani N. Health-related quality of life in men with erectile dysfunction. J Gen Intern Med 1998; 13: 15966
  • 24
    Montorsi F, Padma-Nathan H, Glina S. Erectile function and assessments of erection hardness correlate positively with measures of emotional well-being, sexual satisfaction, and treatment satisfaction in men with erectile dysfunction treated with sildenafil citrate (Viagra). Urology 2006; 68: 2637
  • 25
    Goldstein I. A 36-week, open label, non-comparative study to assess the long-term safety of sildenafil citrate (VIAGRA) in patients with erectile dysfunction. Int J Clin Pract Suppl 1999; 102: 89
  • 26
    Levinson IP, Creanga DL. Appropriate starting dose of VIAGRA® (sildenafil citrate) for the treatment of erectile dysfunction: pooled analysis of flexible-dose, placebo-controlled, double-blind studies and open-label extension. J Sex Med 2005; 2: 36
  • 27
    Sheu JY, Chen KK, Lin AT et al. Long-term efficacy and safety of sildenafil for patients with erectile dysfunction. J Chin Med Assoc 2003; 66: 4806